Ketoprofen suppresses triple negative breast cancer cell growth by inducing apoptosis and inhibiting autophagy

Product Description

Active Tumor Necrosis Factor Alpha (TNFa), APA133Hu01

Marizomib suppresses triple-negative breast cancer via proteasome and oxidative phosphorylation inhibition

The molecular mechanism of the anticancer effect of Artonin E in MDA-MB 231 triple negative breast cancer cells

WO2020061349A1 - Diagnostic methods for triple-negative breast cancer - Google Patents

Frontiers Strategies to overcome myeloid cell induced immune suppression in the tumor microenvironment

Apoptosis: A Review of Programmed Cell Death - Susan Elmore, 2007

ABC multidrug transporters: structure, function and role in chemoresistance

Platinum(IV) and platinum(II) anticancer complexes with biologically active releasable ligands - ScienceDirect

Synthesis and biological evaluation of RGD conjugated with Ketoprofen/Naproxen and radiolabeled with [99mTc] via N4(GGAG) for αVβ3 integrin-targeted drug delivery. - Abstract - Europe PMC

Frontiers Saikosaponin A Inhibits Triple-Negative Breast Cancer Growth and Metastasis Through Downregulation of CXCR4

Carboranyl Analogues of Ketoprofen with Cytostatic Activity against Human Melanoma and Colon Cancer Cell Lines

The molecular mechanism of the anticancer effect of Artonin E in MDA-MB 231 triple negative breast cancer cells

β, β-Dimethylacrylshikonin potentiates paclitaxel activity, suppresses immune evasion and triple negative breast cancer progression via STAT3Y705 phosphorylation inhibition based on network pharmacology and transcriptomics analysis - ScienceDirect

Ketoprofen, CAS 22071-15-4